During that time, the word "moor" itself underwent a change of definition: Originally meaning a Muslim, it became a generic term for any person from Africa or from the Ottoman Empire.
Mensing that found generic drugmakers are not required to strengthen labeling if alerted to side effects, even if the same change has not been made to labeling for the branded medicine ( here is the ruling).
In that instance, the US Supreme court decided generic drugmakers are not required to strengthen labeling if alerted to side effects, even when the same change has not been made to the labeling for the branded medicines.